These results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two support the principle of focusing on ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Diseases. A study study released https://richardp713kke6.ageeksblog.com/profile